Results 31 to 40 of about 528,622 (127)

CytoSorb® usage in a dual antiplatelet agent treated patient during CABG and broken guidewire retrieval from right coronary artery ostium [PDF]

open access: yesInternational Journal of Medical Device and Adjuvant Treatments, 2022
Objective: We report a case of a patient undergoing Open Coronary Artery Bypass Graft Surgery (CABG) with CytoSorb® under dual antiplatelet therapy (DAPT) with a broken guidewire in RCA ostium.
N. Kumar, V. Keshri, R. Bhuyan
doaj   +1 more source

Immunomodulation by Hemoadsorption—Changes in Hepatic Biotransformation Capacity in Sepsis and Septic Shock: A Prospective Study

open access: yesBiomedicines, 2022
Background: Sepsis is often associated with liver dysfunction, which is an indicator of poor outcomes. Specific diagnostic tools that detect hepatic dysfunction in its early stages are scarce.
Janina Praxenthaler   +6 more
doaj   +1 more source

Hemoadsorption Treatment with CytoSorb® in Probable Hemophagocytic Lymphohistiocytosis: A Role as Adjunctive Therapy? [PDF]

open access: yesCase Rep Hematol, 2021
Acute hemophagocytic lymphohistiocytosis (HLH) is a life-threatening disease, with an annual incidence of 1 : 800,000 people. The disease is characterized by a cytokine storm, with concomitant macrophage and natural killer (NK) cell activation; death can
Ceruti S   +4 more
europepmc   +2 more sources

Effective Treatment of Acute Tricyclic Antidepressant Poisoning with Cardiogenic Shock and Severe Rhabdomyolysis Using ECMO and CytoSorb® Adsorber. [PDF]

open access: yesAm J Case Rep, 2023
BACKGROUND Tricyclic antidepressant (TCA) drugs are a common cause of fatal poisoning because of their cardiotoxic and arrhythmogenic effects. Classic supportive management includes sodium bicarbonate, gastrointestinal chelating agents, and vasopressors.
Zitoune Z   +6 more
europepmc   +2 more sources

A New Apheresis Device for Antithrombotic Drug Removal during Off-Pump Coronary Artery Bypass Surgery

open access: yesMedicina, 2022
Background and Objectives: The hemoadsorption device CytoSorb® (CytoSorbents Inc., Princeton, NJ, USA) has been shown to efficiently remove ticagrelor from whole blood in vitro.
Helmut Mair   +7 more
doaj   +1 more source

Table1_Impact of CytoSorb® on interleukin-6 in cardiac surgery.pdf

open access: yes, 2023
ObjectiveCardiac surgery is known to activate a cascade of inflammatory mediators leading to a systemic inflammatory response. Hemadsorption (HA) devices such as CytoSorb® have been postulated to mitigate an overshooting immune response, which is ...
Daniela Geisler (16902909)   +15 more
core   +1 more source

Effects of the timing and intensity of treatment on septic shock patients treated with CytoSorb®: Clinical experience

open access: yes, 2022
Introduction: A group of adult septic shock patients treated with hemoperfusion (HA) with the Cytosorb® associated with CVVHD were studied to determine (a) the effects of this technique on different clinical variables; and (b) the impact of the pre ...
Samola V.   +13 more
core   +1 more source

Successful Reduction of Creatine Kinase and Myoglobin Levels in Severe Rhabdomyolysis Using Extracorporeal Blood Purification (CytoSorb®) [PDF]

open access: yes, 2020
Rhabdomyolysis, if severe, can lead to acute kidney injury (AKI). Myoglobin is an iron and oxygen-binding protein that is freely filtered by the glomerulus.
Ince, C. (Can)   +13 more
core   +1 more source

Case Report: Prevention of Rhabdomyolysis-Associated Acute Kidney Injury by Extracorporeal Blood Purification With Cytosorb®

open access: yesFrontiers in Pediatrics, 2022
Acute kidney injury (AKI) is a severe complication of rhabdomyolysis. The pathophysiology of rhabdomyolysis-associated AKI is complex, but myoglobin related damage plays a major role.
Simon Rauch   +7 more
doaj   +1 more source

Paediatric patient with dengue fever and associated multi-organ dysfunction syndrome (MODS) receiving hemoadsorption using Cytosorb® – A case report on clinical experience [PDF]

open access: yesInternational Journal of Medical Device and Adjuvant Treatments, 2020
Objective: Dengue is an arboviral disease, spreads by female aedes mosquito, which has hepatotoxic effects on multiple organ systems. Cytokine extracorporeal hemoadsorption (Cytosorb®) is considered to be a successful adjunctive therapy for adult ...
S. Kumar, S. Damera
doaj   +1 more source

Home - About - Disclaimer - Privacy